Assessment and Management of Hepatobiliary Disease 1987
DOI: 10.1007/978-3-642-72631-6_33
|View full text |Cite
|
Sign up to set email alerts
|

Antioxidant and Immunomodulant Effect of Hepatoprotective Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
0
0
Order By: Relevance
“…However, after treatment with ethanolic extract of C. ferruginea and silymarin, there was a decrease in the level of total serum bilirubin in CCL4-induced rats. This agrees with the report of Feher et al (1987) who reported that silymarin can reduce the elevated level of total bilirubin caused by hepatic injury. For C. ferruginea, this could be due to its antioxidant activity (Okoro, 2020b;Ita, 2017).…”
Section: Okoro E Osupporting
confidence: 93%
“…However, after treatment with ethanolic extract of C. ferruginea and silymarin, there was a decrease in the level of total serum bilirubin in CCL4-induced rats. This agrees with the report of Feher et al (1987) who reported that silymarin can reduce the elevated level of total bilirubin caused by hepatic injury. For C. ferruginea, this could be due to its antioxidant activity (Okoro, 2020b;Ita, 2017).…”
Section: Okoro E Osupporting
confidence: 93%